Literature DB >> 15543566

Insulin-like growth factors in patients with liver cysts.

Olgica Nedić1, J Anna Nikolić, Ivona Baricević, Biljana Jovanović, Natasa Ilić.   

Abstract

Insulin-like growth factors (IGFs) play an important role in cell growth and differentiation, and the liver is the main source of IGFs and IGF-binding proteins (IGFBPs) that appear in the circulation. The effect of liver cysts on the circulating IGF system was studied in this work. Serum concentrations of IGF-I and -II were measured by radioimmunoassay, IGFBP patterns were characterised by ligand-affinity and immunoblotting, and a lectin-binding assay was used to investigate the glyco component of IGFBP-3 complexes. IGF-I and -II concentrations in patients with cysts were significantly lower compared to those in healthy individuals (P<0.0001 and P<0.01, respectively), and the decrease was related to age but not sex. The overall mean concentrations of IGF-I and -II were not significantly different whether the cysts were caused by Echinococcus granulosus, cross-reactive pathologies, or some other factor. IGFBP profiles correlated with the amount of IGF present: patients with lower IGF-I concentrations expressed decreased IGFBP-3 and elevated IGFBP-2 levels. Increased IGFBP-3 proteolytic activity in the patients' blood was not detected by immunoblotting. In the lectin-binding assay, IGFBP-3 complexes in the circulation of patients demonstrated reactivity similar to that in healthy persons, suggesting that the overall structure of the saccharide moieties of the IGFBP-3 complexes was not significantly altered due to liver cyst formation. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15543566      PMCID: PMC6807715          DOI: 10.1002/jcla.20042

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  20 in total

Review 1.  ABC of diseases of liver, pancreas, and biliary system.

Authors:  J E Krige; I J Beckingham
Journal:  BMJ       Date:  2001-03-03

2.  A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.

Authors:  G Van den Berghe; R C Baxter; F Weekers; P Wouters; C Y Bowers; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

3.  Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies.

Authors:  P Hossenlopp; D Seurin; B Segovia-Quinson; S Hardouin; M Binoux
Journal:  Anal Biochem       Date:  1986-04       Impact factor: 3.365

4.  Immunoassay of insulin-like growth factor-binding protein-3 (IGFBP-3): new means to quantifying IGFBP-3 proteolysis.

Authors:  A Diamandi; J Mistry; R G Krishna; J Khosravi
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

Review 5.  Laboratory diagnosis of cystic hydatic disease.

Authors:  M F Biava; A Dao; B Fortier
Journal:  World J Surg       Date:  2001-01       Impact factor: 3.352

6.  Serum insulin-like growth factor (IGF)-II is more closely associated with liver dysfunction than is IGF-I in patients with cirrhosis.

Authors:  J A Nikolić; V Todorović; M Bozić; L Tosić; M Bulajić; T Alempijević; O Nedić; R Masnikosa
Journal:  Clin Chim Acta       Date:  2000-04       Impact factor: 3.786

7.  Differential immunodiagnosis between cystic hydatid disease and other cross-reactive pathologies.

Authors:  D Poretti; E Felleisen; F Grimm; M Pfister; F Teuscher; C Zuercher; J Reichen; B Gottstein
Journal:  Am J Trop Med Hyg       Date:  1999-02       Impact factor: 2.345

8.  GH is a regulator of IGF2 promoter-specific transcription in human liver.

Authors:  H von Horn; C Ekström; E Ellis; H Olivecrona; C Einarsson; M Tally; T J Ekström
Journal:  J Endocrinol       Date:  2002-03       Impact factor: 4.286

9.  Differential expression of IGF-I and IGF-binding protein-1 and -2 in periportal and perivenous zones of rat liver.

Authors:  S J Hazel; A C Nordqvist; K Hall; M Nilsson; M Schalling
Journal:  J Endocrinol       Date:  1998-05       Impact factor: 4.286

10.  Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.

Authors:  J Kratzsch; W F Blum; E Schenker; E Keller
Journal:  Exp Clin Endocrinol Diabetes       Date:  1995       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.